The Effect of Subclinical Leaflet Thrombosis and Prosthesis Type on Transcatheter Aortic Valve Degeneration (POPular PET TAVI) - Trial NCT05758662
Access comprehensive clinical trial information for NCT05758662 through Pure Global AI's free database. This phase not specified trial is sponsored by St. Antonius Hospital and is currently Not yet recruiting. The study focuses on Aortic Valve Stenosis. Target enrollment is 180 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
18F-sodium fluoride Positron Emission Tomography (18F-NaF PET), Cardiac Computed Tomography (CT), Transthoracic Echocardiography (TTE)
Observational
diagnostic test
Sponsor & Location
St. Antonius Hospital
Timeline & Enrollment
N/A
Apr 01, 2023
Oct 01, 2025
Primary Outcome
Quantified bioprosthetic micro-calcification activity,Subclinical Leaflet Thrombosis,Valve dysfunction
Summary
A multicentre cross-sectional cohort study to assess the difference in bioprosthetic
 micro-calcification activity, detected with 18F-NaF PET-CT, as early marker of transcatheter
 valve degeneration, between patients with vs. without subclinical leaflet thrombosis at five
 years after TAVI; and between patients with intra-annular vs. supra-annular TAVI prostheses.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05758662
Non-Device Trial